Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Bioequivalence
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Australia === In [[Australia]], the [[Therapeutics Goods Administration]] (TGA) considers preparations to be bioequivalent if the 90% [[confidence interval]]s (90% CI) of the rate ratios, between the two preparations, of ''C''<sub>max</sub> and AUC lie in the range 0.80β1.25. ''T''<sub>max</sub> should also be similar between the products.<ref name="Birkett_2003"/> There are tighter requirements for drugs with a narrow [[therapeutic index]] and/or saturable metabolism – thus no generic products exist on the Australian market for [[digoxin]] or [[phenytoin]] for instance.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)